45 days, above it on 51, and below it on 84. Patients received heparin for a median of four days, and the kaolin cephalin clotting time was within the therapeutic range for a median of one day in each patient (though never in 13 patients) (table). Interestingly, there was no trend towards improved control with duration of treatment.
No takes yet. Share an insight, caveat, or question.
MOORE et al. (1985) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: